Monday, June 29, 2026 7:27 PM ET
4 hours ago
Medicare is about to cover obesity drugs — but many seniors may not know it yet1 day ago
Estrogen patches are hard to find, and it may not be resolved any time soon3 days ago
Chan Zuckerberg Initiative's Biohub to open new rare disease funding round4 days ago
This life sciences stock has a secret weapon, and AI will only make it more valuable5 days ago
Extreme heat grips Europe as red alerts issued in UK, France, Spain and Italy5 days ago
UPS to invest $48 million in cold facilities amid GLP-1 boom6 days ago
SNAP restrictions could change what shoppers buy — and food giants are watching9 days ago
U.S. opens tariff probe targeting Germany's drug pricing policies10 days ago
What this biotech's volatile stock price tells you about the weight loss market right now10 days ago
UniQure to seek FDA approval for Huntington's disease gene therapy in reversal10 days ago
Biotech IPO revival faces competition from cash-rich big pharma buyers13 days ago
Centene to offer buyouts to some employees as health insurer cuts costs14 days ago
Drugmakers race to find a place in the next wave of obesity drugs16 days ago
CVS Health executives on reducing healthcare's biggest pain points16 days ago
Rollins called screwworm a 'little pest' amid U.S. spread. Last year, she called it 'terrifying'18 days ago
How screwworm in U.S. cattle herds could re-inflate record beef prices19 days ago
The space race is coming for pharma: Why drug development is heading to orbit19 days ago
Nuvalent shares surge 39% after GSK agrees to buy drugmaker for $10.6 billion20 days ago
Jim Cramer says he can't sell Eli Lilly despite its massive run up. Here's why21 days ago
GLP-1 pioneers Novo and Lilly compete on pills, prepare to pitch seniors21 days ago
Food supply 'not at risk' after new Texas screwworm cases, USDA secretary says21 days ago
Weight loss drug maker sinks 23% after new safety data spooks investors21 days ago
U.S. confirms second Texas screwworm case, Canada restricts livestock imports23 days ago
AstraZeneca CEO says AI is reshaping drug development — and helping boost the odds of success24 days ago
Warren Buffett disciple Guy Spier's rare cancer changed how he values everything24 days ago
An 'EpiPen' for heart attacks?: The market has yet to give this drug stock credit24 days ago
As the World Cup kicks off, health officials are focused on more than Ebola25 days ago
'Buying stuff like it's going out of fashion': Biotech M&A on track for best year since pre-Covid25 days ago
Eli Lilly's top dealmaker says don't be surprised to see more M&A25 days ago
Biotech Abivax sinks 43% as cancer cases cloud trial data for bowel disease drug20 days ago
Lung cancer drug from Akeso, Summit cut risk of death by 34% in late-stage trial27 days ago